Events Archives - Page 72 of 128

2 minute read

Geron Announces Upcoming Oral Presentation At 2023 American Society Of Clinical Oncology Annual Meeting Of Imetelstat Data From IMerge Phase 3 Lower Risk MDS Trial

April 26, 10:06 AM

Geron Corporation (NASDAQ:GERN), a late-stage clinical biopharmaceutical company, today announced that data from the pivotal IMerge Phase 3 clinical trial evaluating the Company's first-in-class telomerase inhibitor,

GERN

2 minute read

Blueprint Medicines to Present New Clinical Data Across Broad Precision Therapy Pipeline At 2023 ASCO Annual Meeting

By Happy Mohamed

April 26, 10:04 AM

Blueprint Medicines Corporation (NASDAQ:BPMC) today announced the acceptance of clinical abstracts for multiple programs across its precision therapy portfolio at the 2023 American Society of Clinical Oncology (ASCO)

BPMC

2 minute read

IN8bio Announces Oral Presentation Of New INB-200 Phase 1 Data In Glioblastoma To Be Presented At 2023 ASCO Annual Meeting

By Happy Mohamed

April 26, 10:04 AM

IN8bio, Inc. (NASDAQ:INAB), a leading clinical-stage biopharmaceutical company focused on innovative gamma-delta T cell therapies, today announced an oral presentation at the upcoming 2023 American Society of Clinical

INAB

3 minute read

Novocure Announces Presentation Of Results Of The LUNAR Phase 3 Clinical Trial In Non-Small Cell Lung Cancer At 2023 American Society Of Clinical Oncology Annual Meeting

By Happy Mohamed

April 26, 10:03 AM

Novocure (NASDAQ:NVCR) today announced the results of the LUNAR phase 3 clinical trial in metastatic, non-small cell lung cancer (NSCLC) will be presented for the first time at the 2023 American Society of Clinical

NVCR

2 minute read

Zentalis To Present Clinical Data In Ovarian Cancer Combining Azenosertib And Chemotherapy, Including Clinical Support For Cyclin E1 Expression As Predictive Marker For Clinical Benefit From Azenosertib At The 2023 ASCO Annual Meeting

By Happy Mohamed

April 26, 10:02 AM

Builds on recent preclinical data presented at AACR supporting the use of CCNE1 amplification and / or Cyclin E1 expression as a potential marker for the enrichment of patient populations for treatment with

ZNTL

3 minute read

Bolt Biotherapeutics To Present Clinical Data From Phase 1 Dose-Escalation Trial Of BDC-1001 in HER2-Expressing Tumors At 2023 ASCO Annual Meeting

By Happy Mohamed

April 26, 10:02 AM

Bolt Biotherapeutics, Inc. (NASDAQ:BOLT), a clinical-stage biopharmaceutical company pioneering novel immuno-oncology therapeutics for the treatment of cancer, today announced that it will present a poster with clinical

BOLT

1 minute read

Galera To Present 1-Year Reductions In Cisplatin-Related Chronic Kidney Disease Data From ROMAN Trial At 2023 American Society Of Clinical Oncology Annual Meeting

By Happy Mohamed

April 26, 10:01 AM

Galera Therapeutics, Inc. (NASDAQ:GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform

GRTX

2 minute read

Awaiting Q1 GDP Results: Can US Economy Fend Off Recession Fears?

By Piero Cingari

April 26, 9:27 AM

On Thursday, the U.S. Bureau of Economic Analysis will announce its preliminary estimates of the first-quarter gross domestic product.

SPY

2 minute read

Events
News

NUBURU Announces Blue Laser Showcase At Upcoming Conferences In U.S. And Europe

By Happy Mohamed

April 25, 9:50 AM

NUBURU, Inc. ("NUBURU" or the "Company") (NYSE:BURU), a leading innovator in high-power and high-brightness industrial blue laser technology, today announced that the Company plans to showcase its

BURU

2 minute read

EXCLUSIVE: Sale-Leasebacks? Not For Verano. ‘Leverage Your Own Cash Flow,’ Exec Says

By Nina Zdinjak

April 25, 9:06 AM

Verano Holdings (OTCQX: VRNOF) chief investment officer Aaron Miles believes that leveraging cash flow is the best way to build a cannabis business.

ACRHF